Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
Please join us for an ECHO webinar on Tuesday Jan 25, 2022 (11 am – 12 pm EST) featuring Dr. Elena Di Martino (Co-Founder & Chief Scientific Officer, ViTAA Medical Solutions; Professor, Biomedical Engineering, University of Calgary).
Dr. Di Martino’s presentation entitled, “A new paradigm for the assessment of aortic aneurysms”, will feature an overview of ViTAA Medical Solutions, its technologies and the story behind its success.
ViTAA Medical Solutions is a digital health company headquartered in Montreal, that is focused on employing software to aid physicians in personalizing the care of patients with aortic aneurysms. ViTAA’s technology has been developed and refined over the last decade by the team led by Prof. Elena Di Martino at the University of Calgary in collaboration with vascular surgeon Dr. Randy Moore.
Register in advance for this meeting: https://us02web.zoom.us/meeting/register/tZYkduihqzsvEtA5KRby1ghGjlw_YRpyGqUS
For more on the ECHO program, click here.
